Articles
A product is no longer enough

A product is no longer enough

Hanno Wolfram discusses key account management – the sales model of the future. Pharma’s past experience relates to launching, promoting and selling drugs. This era is coming to the same end as the times of...

Articles
Should pharma companies outsource clinical trials?

Should pharma companies outsource clinical trials?

Jeremy Spivey discusses the pros and cons of outsourcing clinical trials, looking at clinical strategies, patient recruitment and global challenges. A recent news story suggested that unnecessary clinical trials procedures cost the pharmaceutical industry...

Articles
Strategy and evaluations part two: developing sales estimates

Strategy and evaluations part two: developing sales estimate...

In part two of three, Jean-Louis continues his discussion around business strategy and evaluations, this time looking at how pharma can develop accurate sales estimates. In my previous article, we became the eye of the practitioner in order to propose a new...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more